CN113679399A - Trigeminal semilunar ganglion compression device - Google Patents
Trigeminal semilunar ganglion compression device Download PDFInfo
- Publication number
- CN113679399A CN113679399A CN202010409196.5A CN202010409196A CN113679399A CN 113679399 A CN113679399 A CN 113679399A CN 202010409196 A CN202010409196 A CN 202010409196A CN 113679399 A CN113679399 A CN 113679399A
- Authority
- CN
- China
- Prior art keywords
- balloon
- electrode
- channel
- support tube
- lead
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000006835 compression Effects 0.000 title claims abstract description 29
- 238000007906 compression Methods 0.000 title claims abstract description 29
- 210000000427 trigeminal ganglion Anatomy 0.000 title abstract description 18
- 239000007788 liquid Substances 0.000 claims abstract description 18
- 230000001537 neural effect Effects 0.000 claims abstract description 4
- 229910052751 metal Inorganic materials 0.000 claims description 35
- 239000002184 metal Substances 0.000 claims description 35
- 239000012530 fluid Substances 0.000 claims description 27
- 238000002347 injection Methods 0.000 claims description 15
- 239000007924 injection Substances 0.000 claims description 15
- 238000007789 sealing Methods 0.000 claims description 11
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 claims description 7
- 238000011282 treatment Methods 0.000 abstract description 28
- 238000005516 engineering process Methods 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 230000007012 clinical effect Effects 0.000 abstract description 4
- 230000006872 improvement Effects 0.000 abstract description 4
- 238000004393 prognosis Methods 0.000 abstract description 4
- 210000005036 nerve Anatomy 0.000 description 25
- 210000003901 trigeminal nerve Anatomy 0.000 description 19
- 230000000694 effects Effects 0.000 description 16
- 238000012806 monitoring device Methods 0.000 description 12
- 239000002872 contrast media Substances 0.000 description 9
- 210000003128 head Anatomy 0.000 description 8
- 238000000034 method Methods 0.000 description 5
- 230000008058 pain sensation Effects 0.000 description 4
- 239000002861 polymer material Substances 0.000 description 4
- 210000005077 saccule Anatomy 0.000 description 4
- 230000007547 defect Effects 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 238000009434 installation Methods 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000003466 welding Methods 0.000 description 3
- 206010029174 Nerve compression Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000004804 winding Methods 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- 241001272720 Medialuna californiensis Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
- A61B6/481—Diagnostic techniques involving the use of contrast agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1002—Balloon catheters characterised by balloon shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1079—Balloon catheters with special features or adapted for special applications having radio-opaque markers in the region of the balloon
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- High Energy & Nuclear Physics (AREA)
- Radiology & Medical Imaging (AREA)
- Optics & Photonics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
The invention provides a trigeminal semilunar junction compression device, which comprises: the sacculus, the stay tube, first electrode, the second electrode, first wire, second wire and connecting piece, seted up on the connecting piece and annotated the liquid chamber, stay tube one end is inserted in the sacculus, the other end and the connecting piece of stay tube are connected, and the stay tube with annotate liquid chamber intercommunication, first electrode and second electrode all are used for gathering neural signal, first electrode sets up the near-end at the sacculus, first wire one end is connected with first electrode, the other end extends to the sacculus outside, the second electrode is configured to can laminate at patient's face, the second wire is connected with the second electrode. The trigeminal semilunar ganglion compression device can achieve the clinical effects of rapid and accurate treatment and prognosis improvement, can improve the cure rate of diseases, and is beneficial to the wide popularization and application of the trigeminal semilunar ganglion balloon compression technology.
Description
Technical Field
The invention relates to the field of medical instruments, in particular to a trigeminal semilunar junction compression device.
Background
The trigeminal balloon compression technology (PBC) has the action mechanism that the balloon is inflated at the trigeminal ganglion to compress the mechanically injured nerve root and the trigeminal ganglion, so that pain sensation nerve signals in the trigeminal nerve region are weakened, and the treatment effect is achieved. Generally, the main factors influencing the treatment effect in the trigeminal semilunar ganglion sacculus compression operation comprise the sacculus filling shape and the compression time, wherein the shape of the sacculus is not easy to control, a doctor mainly judges whether the sacculus is filled to reach an ideal shape (such as a pear shape) through an image, the judgment on the sacculus filling shape is greatly influenced by the subjective factors of the doctor, the treatment effect cannot be quantitatively evaluated, the treatment effect between different doctors is greatly different, even the treatment effect between different patients treated by the same doctor is also greatly different, the cure rate of diseases is influenced, and the popularization and the application of the trigeminal semilunar ganglion sacculus compression technology are not facilitated.
Disclosure of Invention
The invention aims to provide a trigeminal semilunar junction compression device which can improve the cure rate of diseases and is beneficial to popularization and application of a trigeminal semilunar junction balloon compression technology.
In order to achieve the purpose, the invention adopts the following technical scheme:
a trigeminal semilunar compression device comprising: sacculus, stay tube, first electrode, second electrode, first wire, second wire and connecting piece, it annotates the liquid chamber to have seted up on the connecting piece, stay tube one end is inserted in the sacculus, the other end of stay tube with the connecting piece is connected, just the stay tube with annotate the liquid chamber intercommunication, first electrode with the second electrode all is used for gathering neural signal, first electrode sets up the near-end of sacculus, first wire one end with first electrode connection, the other end extends to the sacculus outside, the second electrode is configured to can laminate at patient's face, the second wire with second electrode connection.
In one embodiment, the supporting tube is provided with a mounting part, and the second electrode is detachably connected with the mounting part.
In one embodiment, the second electrode is connected with the mounting part in a clamping mode.
In one embodiment, the trigeminal semilunar junction compression device further comprises a sealing head, wherein the sealing head is provided with an arc-shaped surface and fixedly connected with the support tube through the balloon.
In one embodiment, the trigeminal semilunar pressure device further comprises: the balloon fixing device comprises a first metal buckle ring and a second metal buckle ring, wherein the first metal buckle ring is sleeved on the outer side of the far end of the balloon, the far end of the balloon is fastened and fixed on the supporting tube through the first metal buckle ring, the second metal buckle ring is sleeved on the outer side of the near end of the balloon, and the near end of the balloon is fastened and fixed on the supporting tube through the second metal buckle ring.
In one embodiment, the trigeminal semilunar pressure device further comprises: and the injector is connected with the connecting piece in an inserting manner.
In one embodiment, the injector is further provided with a threaded part, the connecting piece is provided with threads, and the threaded part is in threaded connection with the connecting piece.
In one embodiment, the support tube is a single lumen tube or a multi-lumen tube.
In one embodiment, the support tube has two lumens, wherein,
the two cavities respectively form a fluid channel and a guide wire channel, and a guide wire through hole is formed in the connecting piece; the fluid channel is respectively communicated with the saccule and the liquid injection cavity, and the wire guide channel is respectively communicated with the saccule and the wire guide through hole; or the like, or, alternatively,
the two cavities respectively form a fluid channel and a wire channel, and the connecting piece is provided with a lead channel; the fluid channel is respectively communicated with the balloon and the liquid injection cavity, and the lead channel is communicated with the lead channel.
In one embodiment, the support tube has at least three cavities, the at least three cavities form a fluid channel, a wire channel and a wire guide channel respectively, and the connecting piece is provided with a lead channel and a wire guide through hole; the fluid channel is respectively communicated with the balloon and the liquid injection cavity, the wire channel is communicated with the lead channel, and the wire guide channel is respectively communicated with the balloon and the wire guide through hole.
When the half-moon-shaped trigeminal nerve compression device is used, the first electrode and the second electrode are respectively connected with an external electrophysiological nerve signal monitoring device through the first lead and the second lead, the magnitude of trigeminal pain sensation nerve signals of a patient before and during an operation can be monitored through the electrophysiological nerve signal monitoring device, so that whether the expected pain disappearance effect is achieved through the difference of nerve signals can be judged, the treatment effect can be quantitatively evaluated, and the defect that the treatment effect is uneven due to the fact that no quantitative parameter is used for evaluating the treatment standard clinically at present can be effectively overcome. Clinical experiments prove that the trigeminal semilunar ganglion compression device can achieve the clinical effects of accurate treatment, quick treatment, prognosis improvement and complication reduction by monitoring the nerve signal difference value before and after treatment, can improve the disease cure rate, and is beneficial to wide popularization and application of the trigeminal semilunar ganglion balloon compression technology.
Drawings
FIG. 1 is a schematic structural view of a half-moon compression device of the trigeminal nerve according to the first embodiment;
FIG. 2 is a schematic diagram of a balloon in one embodiment;
FIG. 3 is a schematic view of a balloon in another embodiment;
FIG. 4 is a schematic structural view of a head according to an embodiment;
FIG. 5 is a schematic diagram of the structure of the syringe in one embodiment;
FIG. 6 is a schematic structural view of a semilunar pressure device for trigeminal nerve according to the second embodiment;
FIG. 7 is a cross-sectional view of the support tube in the meniscal compression device of FIG. 6;
FIG. 8 is a schematic structural view of a semilunar pressure device for trigeminal nerve according to a third embodiment;
FIG. 9 is a cross-sectional view of the support tube in the meniscal compression device of FIG. 8;
FIG. 10 is a schematic structural view of a semilunar pressure device for trigeminal nerve according to an embodiment IV;
fig. 11 is a structural sectional view of a support tube in the trigeminal semilunar junction compression device shown in fig. 10.
Description of reference numerals:
10-balloon, 14-first electrode, 15-second electrode, 16-first lead, 17-second lead, 18-connector, 19-end socket, 20-first metal retaining ring, 21-second metal retaining ring, 22-injector, 30-support tube, 31-fluid channel, 32-lead channel, 33-guide wire channel, 34-inner support tube, 35-outer support tube, 36-through hole;
181-liquid injection cavity, 182-lead channel, 183-guide wire through hole, 191-arc surface and 221-thread part.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
In the description of the present invention, it is to be understood that the terms "upper", "lower", "front", "rear", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", etc., indicate orientations or positional relationships based on those shown in the drawings, and are only for convenience of description and simplicity of description, but do not indicate or imply that the device or element being referred to must have a particular orientation, be constructed and operated in a particular orientation, and thus, are not to be construed as limiting the present invention.
Example one
Referring to fig. 1 to 5, an embodiment of the apparatus for compressing semilunar junction of trigeminal nerve includes: the utility model provides a sacculus 10, the stay tube 30, first electrode 14, the second electrode 15, first wire 16, the second wire 17 and connecting piece 18, seted up on the connecting piece 18 and annotated the liquid chamber 181, stay tube 30 one end is inserted in sacculus 10, the other end and the connecting piece 18 of stay tube 30 are connected, and stay tube 30 communicates with annotating the liquid chamber 181, first electrode 14 and second electrode 15 all are used for gathering neural signal, first electrode 14 sets up the near-end at sacculus 10, first wire 16 one end is connected with first electrode 14, the other end extends to the sacculus 10 outside, second electrode 15 is configured to can laminate at patient's face, second wire 17 is connected with second electrode 15.
In one embodiment, the first electrode 14 and the second electrode 15 may be, but are not limited to, sheet-like or tubular, with the first electrode 14 being fixedly secured to the support tube 30 on the proximal side of the balloon 10 and the second electrode 15 being configured to fit against the patient's face in use. Specifically, the distal end and the proximal end of the balloon 10 are fixed on the inner support tube 30 by bonding, high-strength fiber winding, welding or heat sealing, the first lead 16 extends to the outside of the balloon 10 and is connected with an external electrophysiological nerve signal monitoring device, and the second lead 17 can be directly connected with the external electrophysiological nerve signal monitoring device. Further, in one embodiment, the first lead 16 and the second lead 17 are respectively connected to the electrophysiological nerve signal monitoring device to form a closed loop. Specifically, in this embodiment, the support tube 30 is a single-lumen tube, the lumen of the support tube 30 serves as both a fluid channel and a guide wire channel, a plurality of circular, elliptical or other through holes 36 are opened on the portion of the support tube 30 located inside the balloon 10, and the contrast agent is injected into the balloon 10 through the through holes 36. Further, the support tube 30 is made of medical polymer material, which may be, but not limited to, PVC, PU, PA, PE, PP, and other medical polymer material.
When the trigeminal semilunar junction compression device is used, the first electrode 14 and the second electrode 15 are respectively connected with an external electrophysiological nerve signal monitoring device through the first lead 16 and the second lead 17, the magnitude of trigeminal pain sensation nerve signals of a patient before and during an operation can be monitored through the electrophysiological nerve signal monitoring device, so that whether expected pain disappearance effect is achieved during treatment can be judged through nerve signal difference, treatment effect can be quantitatively evaluated, and the defect that treatment effect is uneven due to the fact that no quantitative parameter is clinically evaluated according to treatment standards at present can be effectively overcome. Clinical experiments prove that the trigeminal semilunar ganglion compression device can achieve the clinical effects of accurate treatment, quick treatment, prognosis improvement and complication reduction by monitoring the nerve signal difference value before and after treatment, can improve the disease cure rate, and is beneficial to wide popularization and application of the trigeminal semilunar ganglion balloon compression technology.
In one embodiment, the semilunar pressure device further encloses a head 19, the head 19 having an arcuate surface 191, the head 19 passing through the balloon 10 and fixedly connecting to the support tube 30. Specifically, the arc-shaped surface 191 on the seal head 19 can reduce resistance in the advancing process of the trigeminal semilunar junction compression device, ensure smooth advancing and contribute to improving the operation efficiency. The seal head 19 can be made of metal such as stainless steel or medical polymer materials such as PVC. The end cap 19 is partially inserted into the support tube 30 and is fixedly connected to the support tube 30 by means of bonding, welding or heat-sealing.
In one embodiment, the trigeminal semilunar pressure device further comprises: the balloon fixing device comprises a first metal buckle ring 20 and a second metal buckle ring 21, wherein the first metal buckle ring 20 is sleeved on the outer side of the far end of the balloon 10, the first metal buckle ring 20 fastens and fixes the far end of the balloon 10 on the support tube 30, the second metal buckle ring 21 is sleeved on the outer side of the near end of the balloon 10, and the second metal buckle ring 21 fastens and fixes the near end of the balloon 10 on the support tube 30.
Specifically, the first metal buckle 20 and the second metal buckle 21 are both in a metal tube shape or a metal wire shape, the first metal buckle 20 and the second metal buckle 21 may be made of stainless steel, tungsten, titanium, platinum, gold, silver, or an alloy, and the like, and the first metal buckle 20 and the second metal buckle 21 are used for providing X-ray visualization during a surgical procedure and clearly indicating the position of the balloon 10 in human tissue. In this embodiment, the distal end of the balloon 10 is fastened and fixed on the support tube 30 by the first metal buckle 20, and meanwhile, the proximal end of the balloon 10 is fastened and fixed on the support tube 30 by the second metal buckle 21, so that the connection between the balloon 10 and the support tube 30 can be ensured to be stable and reliable.
In one embodiment, the trigeminal semilunar pressure device further comprises: a syringe 22, wherein the syringe 22 is connected with the connecting piece 18 in a plugging way. Specifically, the injector 22 is used for injecting a contrast medium into the injection cavity 181 of the connecting piece 18, and the contrast medium enters the balloon 10 through the supporting tube 30 after entering the injection cavity 181, so that the balloon 10 is inflated and expanded to compress trigeminal nerves, and the treatment purpose is achieved.
In one embodiment, the syringe 22 is further provided with a threaded portion 221, the connector 18 is provided with threads, and the threaded portion 221 is threadedly coupled to the connector 18. In this embodiment, the syringe 22 is screwed to the connector 18 to improve the sealing performance of the trigeminal semilunar ganglion compression device. Specifically, in this embodiment, an internal thread is disposed on the thread portion 221, and an external thread is disposed on the connecting member 18, but in other embodiments, an external thread may be disposed on the thread portion 221, and an internal thread is disposed on the connecting member 18, which may also achieve the same technical effect, and this embodiment is not limited specifically.
In one embodiment, the balloon 10 is a ball-type balloon (as shown in fig. 2) or a capsule-type balloon, and the balloon 10 is made of an elastic material, and may be specifically a compliant or semi-compliant material. In another embodiment, as shown in fig. 3, the balloon 10 is a pear-shaped balloon made of pear-shaped water jacket, and correspondingly, the balloon 10 may be made of natural latex, polyurethane, thermoplastic elastomer polymer material, silicone, rubber, or the like. Specifically, the balloon 10 may change shape with the body tissue after being expanded during surgery, be pear-shaped or otherwise. In practical applications, the balloon 10 may be any shape as required, and the above embodiments are not limited in any way.
In one embodiment, the support tube 30 is provided with a mounting portion 31, and the second electrode 15 is detachably coupled to the mounting portion 31. Specifically, second electrode 15 can be dismantled with installation department 31 and be connected, and trigeminal semilunar festival oppression device during operation takes off second electrode 15 from installation department 31 and laminates at patient's face, installs second electrode 15 on installation department 31 again after the operation, can prevent that second electrode 15 from placing alone and taking place to lose, facilitates the use. Further, in an embodiment, the second electrode 15 is connected to the mounting portion 31 in a snap-fit manner, specifically, the mounting portion 31 may be a groove formed on the outer surface of the support tube 30, or may be a protrusion having a snap groove formed on the outer surface of the support tube 30, and the structure of the specific mounting portion 31 may be arbitrarily set according to actual needs, and the embodiment is not limited in particular.
Example two
In the first embodiment, the supporting tube 30 of the trigeminal semilunar junction compression device is a single-lumen tube, in other embodiments, the supporting tube 30 may also be a multi-lumen tube, and in this embodiment, the supporting tube 30 is a double-lumen tube. Referring to fig. 6 to 7, the support tube 30 has two cavities, the two cavities form a fluid channel 31 and a guide wire channel 33, the connecting member 18 is provided with a guide wire through hole 183, the fluid channel 31 is respectively communicated with the balloon 10 and the injection cavity 181, and the guide wire channel 33 is respectively communicated with the balloon 10 and the guide wire through hole 183. Specifically, the support tube 30 includes an inner support tube 34 and an outer support tube 35, the inner support tube 34 is sleeved inside the outer support tube 35, the inner support tube 34 and the outer support tube 35 are sleeved to form a dual-lumen structure, wherein an inner lumen of the inner support tube 34 is used as a guide wire channel, a gap between the inner support tube 34 and the outer support tube 35 forms another lumen as a fluid channel, and the contrast agent enters the balloon 10 through the gap between the inner support tube 34 and the outer support tube 35, so that a through hole does not need to be formed on the inner support tube 21 and the outer support tube 35. In this embodiment, the support tube 30 is sleeved by the inner support tube 34 and the outer support tube 35 to form a dual-lumen structure, in other embodiments, the support tube 30 may also directly adopt a dual-lumen tube, one lumen of the dual-lumen tube is used as the fluid channel 31, and the other lumen is used as the guide wire channel 33, and the specific structure of the support tube 30 may be selected according to actual needs in practical application, which is not limited in this embodiment.
Further, in this embodiment, one end of the inner support tube 34 is connected to the distal end of the balloon 10, the other end of the inner support tube 34 extends to the outside of the balloon 10 and then is inserted into the connector 18 to communicate with the liquid injection cavity 181, the outer support tube 35 is sleeved on the outside of the inner support tube 34, one end of the outer support tube 35 is connected to the proximal end of the balloon 10, the other end of the outer support tube 35 is connected to the connector 18, the first electrode 14 is fastened and fixed to the inner support tube 34 at the proximal end side of the balloon 10, and the distal end and the proximal end of the balloon 10 are fixed to the outer wall of the inner support tube 34 by bonding, high-strength fiber winding, welding or heat sealing. The first lead 16 extends outside the balloon 10 and is connected to an external electrophysiological nerve signal monitoring device. The first metal buckle 20 is sleeved outside the far end of the balloon 10, the first metal buckle 20 fastens and fixes the far end of the balloon 10 on the inner support tube 34, the second metal buckle 21 is sleeved outside the near end of the balloon 10, and the second metal buckle 21 fastens and fixes the near end of the balloon 10 on the outer support tube 35. The difference between the apparatus for compressing semilunar junction of trigeminal nerve of this embodiment and the apparatus for compressing semilunar junction of trigeminal nerve of the first embodiment is that the number of cavities in the supporting tube 30 is different, and the structure and composition of the components such as the sealing head 19 and the injector 22 in the apparatus are the same, and thus the details are not repeated herein.
EXAMPLE III
Referring to fig. 8 to 9, in the present embodiment, the supporting tube 30 of the apparatus for compressing semilunar junction of trigeminal nerve is a double-lumen tube, two lumens of the supporting tube 30 respectively form a fluid channel 31 and a guide wire channel 32, and the connecting member 18 is provided with a guide wire channel 182; the fluid passage 31 communicates with the balloon 10 and the infusion lumen 181, respectively, and the guidewire passage 32 communicates with the guidewire passage 182.
Specifically, the support tube 30 includes an inner support tube 34 and an outer support tube 35, the inner support tube 34 is sleeved inside the outer support tube 35, the inner support tube 34 and the outer support tube 35 are sleeved to form a dual-lumen structure, wherein an inner lumen of the inner support tube 34 serves as a fluid channel 31 and also serves as a guide wire channel, a gap between the inner support tube 34 and the outer support tube 35 forms another lumen serving as a guide wire channel 32, a through hole 36 is formed in the inner support tube 34, and a contrast agent enters the balloon 10 through the fluid channel 31 of the inner support tube 34 and the through hole 36. In this embodiment, the support tube 30 is sleeved by the inner support tube 34 and the outer support tube 35 to form a dual-lumen structure, in other embodiments, the support tube 30 may also directly adopt a dual-lumen tube, one lumen of the dual-lumen tube is used as the fluid channel 31, and the other lumen is used as the guide wire channel 32, and the specific structure of the support tube 30 may be selected according to actual needs in practical application, which is not limited in this embodiment.
In this embodiment, the first electrode 14 is fastened and fixed on the inner support tube 34 at the proximal end side of the balloon 10, one end of the first lead 16 is connected with the first electrode 14, and the other end of the first lead passes through the lead channel 32 and then extends to the outside of the connecting member 18 through the lead channel 182, and is connected with an external electrophysiological nerve signal monitoring device. In this embodiment, the support tube 30 has the wire channel 32, and the connecting member 18 is provided with the wire channel 182, and the first wire 16 passes through the wire channel 182 after passing through the wire channel 32 and extends to the outside of the connecting member 18, so that the first wire 16 can be effectively prevented from being wound or damaged, and the protection of the first wire 16 is facilitated, and the use is convenient. The difference between the apparatus for compressing semilunar ganglion of trigeminal nerve of the present embodiment and the apparatus for compressing semilunar ganglion of trigeminal nerve of the second embodiment is that the flow passage function of the cavity of the support tube 30 is different, and the structures and the components of other structures, such as the seal head 19 and the injector 22, are the same as those of the first embodiment and the second embodiment, and will not be described herein again.
Example four
Referring to fig. 10 to 11, in the present embodiment, the supporting tube 30 has three cavities, the three cavities respectively form the fluid channel 31, the wire channel 32 and the wire guiding channel 33, and the connecting member 18 is provided with a wire guiding channel 182 and a wire guiding through hole 183; the fluid channel 31 is respectively communicated with the balloon 10 and the liquid injection cavity 181, the guide wire channel 32 is communicated with the lead wire channel 182, and the guide wire channel 33 is respectively communicated with the balloon 10 and the guide wire through hole 183. Specifically, the contrast agent is injected into the balloon 10 through the fluid channel 31, the first guide wire 16 passes through the guide wire channel 32 and then passes through the guide wire channel 182 to extend to the outer side of the connecting piece 18, the guide wire channel 32 is used for the guide wire to pass through, and the fluid channel 31, the guide wire channel 32 and the guide wire channel 33 are separately and independently arranged, so that the use is further facilitated. The difference between the apparatus for compressing semilunar ganglion of trigeminal nerve of this embodiment and the apparatus for compressing semilunar ganglion of embodiment one, embodiment two and embodiment three lies in that the number of cavities in the supporting tube 30 is different, and the structure and composition of the components such as the sealing head 19 and the injector 22 in the apparatus are the same, and will not be described herein again.
The following specifically describes the procedure of using the aforementioned semilunar ganglion pressing device in example three. Specifically, the specific clinical procedure for performing the operation using the trigeminal semilunar pressure device in example three is as follows:
firstly, a patient takes a supine position after general anesthesia, a cloth roll with a proper height is wrapped on a shoulder pad to ensure that the neck is slightly extended, then, a channel is established at a position about 2.5cm away from the affected side corner of the mouth by means of X-ray image positioning under the environment of X-ray, a saccule 10 is inserted, after the positioning of the semilunar node of the trigeminal nerve of which the saccule 10 enters a Meckle's cavity is completed, a second electrode 15 is attached to the face of the patient, and an electrophysiological nerve signal monitoring device is used for measuring a nerve signal before treatment; then, injecting a diluted contrast medium into the inner support tube 34 through the liquid injection cavity 181 of the connecting piece 18 to enable the balloon 10 and the inflation to be expanded, wherein at the moment, the amount of the injected diluted contrast medium can ensure that the Meckle's cavity is just filled, the inflation shape of the balloon 10 is monitored at the lateral side through X-ray images, and meanwhile, a nerve signal in the treatment process is monitored through an electrophysiological nerve signal monitoring device, the shapes and the positions of the balloon 10 and the balloon are continuously adjusted in the process, the balloon 10 and the inflation and compression of the trigeminal nerve meniscus section are kept for 3-7 minutes, when a nerve signal difference value achieving the clinically optimal treatment effect appears, the operation is successful, at the moment, the contrast medium is extracted, and the operation is finished.
The half-moon-shaped trigeminal nerve compression device can be connected with the electrophysiological nerve signal monitoring device to monitor the magnitude of the pain sensation nerve signals of the trigeminal nerve of a patient before and during an operation, so that whether the expected pain disappearance effect is achieved by treatment or not can be judged through the difference of the nerve signals, the treatment effect can be quantitatively evaluated, the defect that the treatment effect is uneven due to the fact that no quantitative parameter is clinically used for evaluating the treatment standard is overcome, the clinical effects of accurate treatment, quick treatment, improvement of prognosis and reduction of complications can be achieved, the disease cure rate can be effectively improved, and the wide popularization and application of the half-moon-shaped trigeminal nerve balloon compression technology are facilitated.
The technical features of the embodiments described above may be arbitrarily combined, and for the sake of brevity, all possible combinations of the technical features in the embodiments described above are not described, but should be considered as being within the scope of the present specification as long as there is no contradiction between the combinations of the technical features.
The above-mentioned embodiments only express several embodiments of the present invention, and the description thereof is more specific and detailed, but not construed as limiting the scope of the invention. It should be noted that, for a person skilled in the art, several variations and modifications can be made without departing from the inventive concept, which falls within the scope of the present invention. Therefore, the protection scope of the present patent shall be subject to the appended claims.
Claims (10)
1. A trigeminal semilunar junction compression device, comprising: a sacculus (10), a support tube (30), a first electrode (14), a second electrode (15), a first lead (16), a second lead (17) and a connecting piece (18), a liquid injection cavity (181) is arranged on the connecting piece (18), one end of the supporting tube (30) is inserted into the balloon (10), the other end of the supporting tube (30) is connected with the connecting piece (18), the supporting tube (30) is communicated with the liquid injection cavity (181), the first electrode (14) and the second electrode (15) are used for collecting neural signals, the first electrode (14) is arranged at the proximal end of the balloon (10), one end of the first lead (16) is connected with the first electrode (14), the other end extends to the outer side of the balloon (10), the second electrode (15) is configured to be conformable to a patient's face, and the second lead (17) is connected to the second electrode (15).
2. A meniscal pressure device as claimed in claim 1 wherein the support tube (30) is provided with a mounting portion (31) and the second electrode (15) is detachably connected to the mounting portion (31).
3. A device according to claim 2, wherein the second electrode (15) is snap-fitted to the mounting portion (31).
4. The apparatus according to claim 1, further comprising a sealing head (19), wherein the sealing head (19) has an arc-shaped surface (1921), and the sealing head (19) passes through the balloon (10) and is fixedly connected to the support tube (30).
5. The apparatus of claim 1, further comprising: the balloon fixing device comprises a first metal buckle ring (20) and a second metal buckle ring (21), wherein the first metal buckle ring (20) is sleeved on the outer side of the far end of the balloon (10), the far end of the balloon (10) is fastened and fixed on the supporting tube (30) through the first metal buckle ring (20), the second metal buckle ring (21) is sleeved on the outer side of the near end of the balloon (10), and the near end of the balloon (10) is fastened and fixed on the supporting tube (30) through the second metal buckle ring (21).
6. The apparatus of claim 1, further comprising: the injector (22), the said injector (22) is connected with said connecting element (18) by plugging.
7. A device as claimed in claim 6, wherein the injector (22) is further provided with a threaded portion (221), the connecting member (18) being provided with a thread, the threaded portion (221) being threadedly connected to the connecting member (18).
8. A device as claimed in any one of claims 1 to 7, wherein the support tube (30) is a single or multi-lumen tube.
9. The device of claim 8, wherein the support tube (30) has two lumens, wherein,
the two cavities respectively form a fluid channel (31) and a guide wire channel (33), and a guide wire through hole (183) is formed in the connecting piece (18); the fluid channel (31) is respectively communicated with the balloon (10) and the liquid injection cavity (181), and the guide wire channel (33) is respectively communicated with the balloon (10) and the guide wire through hole (183); or the like, or, alternatively,
the two cavities form a fluid channel (31) and a wire channel (32) respectively, and a lead channel (182) is formed in the connecting piece (18); the fluid channel (31) is respectively communicated with the balloon (10) and the liquid injection cavity (181), and the lead wire channel (32) is communicated with the lead wire channel (182).
10. The device as claimed in claim 8, wherein the supporting tube (30) has at least three cavities, at least three cavities respectively forming a fluid channel (31), a guide wire channel (32) and a guide wire channel (33), the connecting member (18) is provided with a guide wire channel (182) and a guide wire through hole (183); the fluid channel (31) is respectively communicated with the balloon (10) and the liquid injection cavity (181), the lead wire channel (32) is communicated with the lead wire channel (182), and the lead wire channel (33) is respectively communicated with the balloon (10) and the lead wire through hole (183).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010409196.5A CN113679399A (en) | 2020-05-14 | 2020-05-14 | Trigeminal semilunar ganglion compression device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010409196.5A CN113679399A (en) | 2020-05-14 | 2020-05-14 | Trigeminal semilunar ganglion compression device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113679399A true CN113679399A (en) | 2021-11-23 |
Family
ID=78575279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010409196.5A Pending CN113679399A (en) | 2020-05-14 | 2020-05-14 | Trigeminal semilunar ganglion compression device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113679399A (en) |
-
2020
- 2020-05-14 CN CN202010409196.5A patent/CN113679399A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3640269A (en) | Fluid-conducting instrument insertable in living organisms | |
| CN113679398B (en) | Trigeminal semilunar junction compression device | |
| JP2018509249A (en) | Catheter with balloon at the tip for continuous nerve block | |
| CN110038209B (en) | Balloon dilation device for neurosurgery trigeminal nerve percutaneous treatment | |
| CN113679399A (en) | Trigeminal semilunar ganglion compression device | |
| CN217219839U (en) | Coronary artery direct irrigation head with telescopic length in minimally invasive cardiac surgery | |
| CN110496299A (en) | A kind of double channel catheter for Persistent Csf purification treatment | |
| CN111330138A (en) | Sustainable perfusion drainage tube | |
| CN217285948U (en) | Compression hemostat | |
| CN214259479U (en) | Trigeminal semilunar junction compression device | |
| CN212593459U (en) | Multi-cavity infusion drainage pipeline | |
| CN213465006U (en) | Invasive blood pressure monitoring blood sampling device of dosing | |
| CN213606745U (en) | Multi-cavity puncture needle based on ultrasonic guidance | |
| CN211357361U (en) | Balloon dilatation device for neurosurgical trigeminal percutaneous treatment | |
| CN113679397A (en) | Trigeminal semilunar junction compression device | |
| CN219847810U (en) | Implantable infusion device | |
| CN203154560U (en) | Biatrial catheter | |
| CN219578988U (en) | Intervene puncture drainage device | |
| CN111481241A (en) | Trigeminal semilunar pressure sacculus with constant pressure (constant pressure of additional sacculus) | |
| CN111481240A (en) | Percutaneous trigeminal semilunar ganglion sacculus compression device (skeleton) | |
| CN111481242A (en) | Trigeminal semilunar ganglion compression saccule with automatic exhaust (micropore exhaust) | |
| CN217697619U (en) | Air sac drainage tube | |
| CN210301079U (en) | Trigeminal semilunar junction compression balloon with passivated needle head | |
| CN216536341U (en) | A nursing device for neurosurgery inhales phlegm nursing | |
| CN220070442U (en) | A seal wire device for PICC pipe dystopy is adjusted |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |